The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients

• Egile Nagusiak: Corine deJong (Egilea), Najiba Chargi (Egilea), Gerarda J.M. Herder (Egilea), Simone W.A. vanHaarlem (Egilea), Femke van derMeer (Egilea), Anne S.R. vanLindert (Egilea), Alexandra tenHeuvel (Egilea), Jan Brouwer (Egilea), Pim A. deJong (Egilea), Lot A. Devriese (Egilea), Alwin D.R. Huitema (Egilea), Toine C.G. Egberts (Egilea), Remco deBree (Egilea), Vera H.M. Deneer (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2022-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Chemotherapy‐induced toxicities frequently occur in non‐small cell lung cancer (NSCLC) patients treated with platinum‐based chemotherapy. Low skeletal muscle mass (SMM) has been associated with a higher incidence of toxicities for several types of cancers and cytostatics. The aim...